October 12, 2011
AstraZeneca (AZ) announced on October 10 that it will invest $200 million (around ¥15,300 million) to build a new manufacturing facility in China Medical City (CMC), Taizhou, Jiangsu province, which is scheduled to produce intravenous and oral solid medicines for...read more